title: Effect of IL-2 therapy on plasma hepatitis C virus-RNA levels in HIV/hepatitis C virus co-infected patients.
authors.forename: H
authors.initials: H
authors.lastname: Valdez
authors.forename: J A
authors.initials: JA
authors.lastname: Metcalf
authors.forename: B M
authors.initials: BM
authors.lastname: Gripshover
authors.forename: J M
authors.initials: JM
authors.lastname: Jacobson
authors.forename: R
authors.initials: R
authors.lastname: Mitsuyasu
authors.forename: M M
authors.initials: MM
authors.lastname: Lederman
mesh_terms: D017088:AIDS-Related Opportunistic Infections / Q000097:blood / Q000188:drug therapy / Q000821:virology*; D000410:Alanine Transaminase / Q000097:blood; D018791:CD4 Lymphocyte Count; D015497:HIV-1 / Q000235:genetics; D016174:Hepacivirus / Q000235:genetics; D006526:Hepatitis C / Q000097:blood / Q000188:drug therapy / Q000821:virology*; D006801:Humans; D007376:Interleukin-2 / Q000008:administration & dosage / Q000627:therapeutic use*; D012367:RNA, Viral / Q000097:blood*; D019562:Viral Load
chemical_list: D007376:Interleukin-2; D012367:RNA, Viral; D000410:Alanine Transaminase